114 related articles for article (PubMed ID: 32595355)
1. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
DurdaĞi S
Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
[TBL] [Abstract][Full Text] [Related]
2. Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease.
Oktay L; Erdemoğlu E; Tolu İ; Yumak Y; Özcan A; Acar E; Büyükkiliç Ş; Olkan A; Durdaği S
Turk J Biol; 2021; 45(4):459-468. PubMed ID: 34803447
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.
Shakya A; Chikhale RV; Bhat HR; Alasmary FA; Almutairi TM; Ghosh SK; Alhajri HM; Alissa SA; Nagar S; Islam MA
Mol Divers; 2022 Feb; 26(1):265-278. PubMed ID: 33786727
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
[TBL] [Abstract][Full Text] [Related]
5. Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach.
Sonawane KD; Barale SS; Dhanavade MJ; Waghmare SR; Nadaf NH; Kamble SA; Mohammed AA; Makandar AM; Fandilolu PM; Dound AS; Naik NM; More VB
Inform Med Unlocked; 2021; 24():100597. PubMed ID: 34075338
[TBL] [Abstract][Full Text] [Related]
6. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by
Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A
J Biomol Struct Dyn; 2023 Jul; ():1-21. PubMed ID: 37482789
[TBL] [Abstract][Full Text] [Related]
7. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy.
Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942
[TBL] [Abstract][Full Text] [Related]
8. Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection.
Oyedara OO; Agbedahunsi JM; Adeyemi FM; Juárez-Saldivar A; Fadare OA; Adetunji CO; Rivera G
Phytomed Plus; 2021 Nov; 1(4):100135. PubMed ID: 35403085
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies.
Elbadwi FA; Khairy EA; Alsamani FO; Mahadi MA; Abdalrahman SE; Ahmed ZAM; Elsayed I; Ibraheem W; Alzain AA
Inform Med Unlocked; 2021; 26():100725. PubMed ID: 34514079
[TBL] [Abstract][Full Text] [Related]
10. Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19.
Sharma T; Baig MH; Khan MI; Alotaibi SS; Alorabi M; Dong JJ
Saudi Pharm J; 2022 Mar; 30(3):217-224. PubMed ID: 35095307
[TBL] [Abstract][Full Text] [Related]
11. Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.
Chen Y; Huang WC; Yang CS; Cheng FJ; Chiu YF; Chen HF; Huynh TK; Huang CF; Chen CH; Wang HC; Hung MC
Am J Cancer Res; 2021; 11(3):827-836. PubMed ID: 33791156
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study.
Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
Struct Chem; 2022; 33(5):1529-1541. PubMed ID: 35345416
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.
Chikhale RV; Gupta VK; Eldesoky GE; Wabaidur SM; Patil SA; Islam MA
J Biomol Struct Dyn; 2020 Aug; ():1-16. PubMed ID: 32741259
[TBL] [Abstract][Full Text] [Related]
14. Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.
Feng Y; Cheng X; Wu S; Mani Saravanan K; Liu W
Struct Chem; 2022; 33(5):1503-1515. PubMed ID: 35571866
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics.
Mahgoub MA; Alnaem A; Fadlelmola M; Abo-Idris M; Makki AA; Abdelgadir AA; Alzain AA
J Biomol Struct Dyn; 2023; 41(14):6775-6788. PubMed ID: 35997154
[TBL] [Abstract][Full Text] [Related]
16. Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors.
Mahmudpour M; Nabipour I; Keshavarz M; Farrokhnia M
Front Chem; 2021; 9():722633. PubMed ID: 34712648
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics.
Mohammed AO; Abo-Idrees MI; Makki AA; Ibraheem W; Alzain AA
Struct Chem; 2022; 33(5):1553-1567. PubMed ID: 35789829
[TBL] [Abstract][Full Text] [Related]
18. Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target.
Ikram S; Ahmad J; Durdagi S
J Mol Graph Model; 2020 Mar; 95():107462. PubMed ID: 31786094
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.
Zhu H; Du W; Song M; Liu Q; Herrmann A; Huang Q
Comput Struct Biotechnol J; 2021; 19():467-476. PubMed ID: 33505639
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies.
Alzain AA; Elbadwi FA
Inform Med Unlocked; 2021; 26():100758. PubMed ID: 34667827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
